EP3454893A4 - A composition comprising antigens and a mucosal adjuvant and a method for using - Google Patents
A composition comprising antigens and a mucosal adjuvant and a method for using Download PDFInfo
- Publication number
- EP3454893A4 EP3454893A4 EP16901833.0A EP16901833A EP3454893A4 EP 3454893 A4 EP3454893 A4 EP 3454893A4 EP 16901833 A EP16901833 A EP 16901833A EP 3454893 A4 EP3454893 A4 EP 3454893A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antigens
- composition
- mucosal adjuvant
- mucosal
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2016/031902 WO2017196318A1 (en) | 2016-05-11 | 2016-05-11 | A composition comprising antigens and a mucosal adjuvant and a method for using |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3454893A1 EP3454893A1 (en) | 2019-03-20 |
EP3454893A4 true EP3454893A4 (en) | 2020-01-01 |
Family
ID=60267492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16901833.0A Withdrawn EP3454893A4 (en) | 2016-05-11 | 2016-05-11 | A composition comprising antigens and a mucosal adjuvant and a method for using |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3454893A4 (en) |
CA (1) | CA3022006A1 (en) |
WO (1) | WO2017196318A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112457397A (en) * | 2020-11-26 | 2021-03-09 | 西北农林科技大学 | Nano antibody of PRRSV N protein and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1001025A2 (en) * | 1998-10-22 | 2000-05-17 | Pfizer Products Inc. | Outer membrane proteins from actinobacillus pleuropneumoniae |
US20110123570A1 (en) * | 2009-11-10 | 2011-05-26 | Boehringer Ingelheim Vetmedica, Inc. | Actinobacillus suis antigens |
WO2014004361A1 (en) * | 2012-06-27 | 2014-01-03 | Merial Limited | Attenuated streptococcus suis vaccines and methods of making and use thereof |
CN104511015A (en) * | 2013-09-30 | 2015-04-15 | 普莱柯生物工程股份有限公司 | Vaccine composition, preparation method and application thereof |
CN110075289A (en) * | 2019-04-19 | 2019-08-02 | 河南省农业科学院畜牧兽医研究所 | A kind of haemophilus parasuis, Streptococcus suis and Actinobacillus pleuropneumoniae triple inactivated vaccine and its application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1742659B1 (en) * | 2004-04-05 | 2013-03-13 | Pah Usa 15 Llc | Microfluidized oil-in-water emulsions and vaccine compositions |
US7829274B2 (en) * | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
JP2011518885A (en) * | 2008-04-28 | 2011-06-30 | ノバルティス アーゲー | Nanoparticles for use in pharmaceutical compositions |
PL2959916T3 (en) * | 2011-02-17 | 2019-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
JP2014519485A (en) * | 2011-04-21 | 2014-08-14 | ユニベルシタイト ユトレヒト ホールディング ベーフェー | Streptococcus bacteriophage lysine for treating gram positive bacteria in companion animals and livestock |
-
2016
- 2016-05-11 CA CA3022006A patent/CA3022006A1/en active Pending
- 2016-05-11 WO PCT/US2016/031902 patent/WO2017196318A1/en unknown
- 2016-05-11 EP EP16901833.0A patent/EP3454893A4/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1001025A2 (en) * | 1998-10-22 | 2000-05-17 | Pfizer Products Inc. | Outer membrane proteins from actinobacillus pleuropneumoniae |
US20110123570A1 (en) * | 2009-11-10 | 2011-05-26 | Boehringer Ingelheim Vetmedica, Inc. | Actinobacillus suis antigens |
WO2014004361A1 (en) * | 2012-06-27 | 2014-01-03 | Merial Limited | Attenuated streptococcus suis vaccines and methods of making and use thereof |
CN104511015A (en) * | 2013-09-30 | 2015-04-15 | 普莱柯生物工程股份有限公司 | Vaccine composition, preparation method and application thereof |
CN110075289A (en) * | 2019-04-19 | 2019-08-02 | 河南省农业科学院畜牧兽医研究所 | A kind of haemophilus parasuis, Streptococcus suis and Actinobacillus pleuropneumoniae triple inactivated vaccine and its application |
Non-Patent Citations (4)
Title |
---|
MAYANK CHATURVEDI ET AL: "A review on mucoadhesive polymer used in nasal drug delivery system", JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, vol. 2, no. 4, 1 October 2011 (2011-10-01), pages 215 - 222, XP055232682, DOI: 10.4103/2231-4040.90876 * |
See also references of WO2017196318A1 * |
SHARAD MANGAL ET AL: "Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine", ARTIFICIAL CELLS, NANOMEDICINE AND BIOTECHNOLOGY, vol. 42, no. 1, 1 February 2014 (2014-02-01), US, pages 47 - 57, XP055645252, ISSN: 2169-1401, DOI: 10.3109/21691401.2013.769447 * |
WANG SHUJING ET AL: "Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies", PROTEIN & CELL, SPRINGER ASIA, BEIJING, CN, vol. 6, no. 7, 6 May 2015 (2015-05-06), pages 480 - 503, XP035507308, ISSN: 1674-800X, [retrieved on 20150506], DOI: 10.1007/S13238-015-0164-2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2017196318A1 (en) | 2017-11-16 |
CA3022006A1 (en) | 2017-11-16 |
EP3454893A1 (en) | 2019-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3378488A4 (en) | Method for enhancing humoral immune response | |
EP3499367A4 (en) | Method and device for starting application | |
EP3484508A4 (en) | Compositions and methods for alphavirus vaccination | |
EP3521511A4 (en) | Water-disintegrable sheet and method for manufacturing water-disintegrable sheet | |
EP3410296A4 (en) | Starting method and device for embedded device | |
EP3273950A4 (en) | Adjuvant compositions and related methods | |
EP3345761A4 (en) | Decorative sheet and method for manufacturing decorative sheet | |
EP3200831A4 (en) | Vaccines having an antigen and interleukin-21 as an adjuvant | |
EP3501802A4 (en) | Method for manufacturing stretchable sheet | |
EP3385286A4 (en) | Vaccine antigen with increased immunogenicity | |
EP3416681A4 (en) | Novel antigen for use in malaria vaccine | |
EP3505038A4 (en) | Water-disintegrable sheet and method for producing water-disintegrable sheet | |
EP3603619A4 (en) | Vaccine adjuvant formulation | |
EP3730620A4 (en) | Cross-immunizing antigen vaccine and method for preparation thereof | |
EP3456324A4 (en) | Method for manufacturing acetaminophen preparation | |
EP3740497A4 (en) | Enhanced immunogenicity for gpi-anchored antigens | |
EP3451393A4 (en) | Light-emitting element and method for preparing same | |
EP3600399A4 (en) | Methods and compositions for vaccinating against malaria | |
EP3176811A4 (en) | Sacrificial film composition, method for preparing same, semiconductor device having voids formed using said composition, and method for manufacturing semiconductor device using said composition | |
EP3677548A4 (en) | Method for manufacturing ultra-porous nano-sio2 | |
EP3223846A4 (en) | Adjuvant compositions and related methods | |
EP3104418B8 (en) | Method and device for texturing a silicon surface | |
EP3766869A4 (en) | Simple preparation method for avibactam | |
EP3434494A4 (en) | Image forming method | |
EP3421463A4 (en) | New toxin and method for preparing intermediate thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181026 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20191204 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/09 20060101ALI20191128BHEP Ipc: A61K 39/02 20060101AFI20191128BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220429 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20221005 |